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Abstract
Progressive retinal atrophy (PRA) in dogs, the canine equivalent of retinitis pigmentosa (RP) in humans, is characterised by
vision loss due to degeneration of the photoreceptor cells in the retina, eventually leading to complete blindness. It affects
more than 100 dog breeds, and is caused by numerous mutations. RP affects 1 in 4000 people in the Western world and
70% of causal mutations remain unknown. Canine diseases are natural models for the study of human diseases and are
becoming increasingly useful for the development of therapies in humans. One variant, prcd-PRA, only accounts for a small
proportion of PRA cases in the Golden Retriever (GR) breed. Using genome-wide association with 27 cases and 19 controls
we identified a novel PRA locus on CFA37 (praw = 1.94610
210, pgenome = 1.0610
25), where a 644 kb region was homozygous
within cases. A frameshift mutation was identified in a solute carrier anion exchanger gene (SLC4A3) located within this
region. This variant was present in 56% of PRA cases and 87% of obligate carriers, and displayed a recessive mode of
inheritance with full penetrance within those lineages in which it segregated. Allele frequencies are approximately 4% in the
UK, 6% in Sweden and 2% in France, but the variant has not been found in GRs from the US. A large proportion of cases
(approximately 44%) remain unexplained, indicating that PRA in this breed is genetically heterogeneous and caused by at
least three mutations. SLC4A3 is important for retinal function and has not previously been associated with spontaneously
occurring retinal degenerations in any other species, including humans.
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Introduction
Retinitis pigmentosa (RP) is the collective name for a group of
inherited human retinal disorders that leads to progressive loss of
vision in approximately 1 in 4000 people [1,2,3]. Rod photore-
ceptor cells are predominantly affected and therefore clinical
symptoms typically include night blindness and loss of peripheral
vision. With disease progression the cones also degenerate
resulting in central vision loss and eventually complete blindness
is possible. To date, 167 genes have been shown to cause a wide
spectrum of retinal disease, including RP (RetNet; http://www.
sph.uth.tmc.edu/retnet/). Mutations in these genes currently only
account for approximately 30% of recessive RP cases. [4].
In animals inherited and progressive retinal diseases are
commonly referred to as progressive retinal atrophy (PRA) and
as in humans PRA is characterised by progressive retinal
degeneration resulting in loss of vision. In typical PRA rod
photoreceptor responses are lost first followed by cone photore-
ceptor responses [5]. Fundus changes observed in PRA are
bilateral and symmetrical and include tapetal hyper-reflectivity in
the early stages followed by vascular attenuation, pigmetary
changes and atrophy of the optic nerve head in the later stages of
disease (Figure S1) [6]. Numerous forms of PRA have been
documented in more than 100 dog breeds and while they exhibit
similar clinical signs, the aetiology, age of onset and rate of
progression vary between and within breeds. Several disease-
causing genes have been reported for some forms of PRA
[7,8,9,10,11,12,13,14,15,16], but many remain undefined.
Canine diseases have already proved valuable natural models
for the study of many varied human conditions such as cardiac
conotruncal malformations [17], myotubular myopathy [18] and
hereditary retinopathies such as Leber congenital amaurosis and
achromatopsia [15,19,20]. Further to this, canine models for
human eye diseases have proved invaluable in gene-therapy
studies, most notably the canine model of Leber congenital
amaurosis associated with RPE65 [21,22].
Most PRA cases in the Golden Retriever (GR) are clinically
indistinguishable from other forms of PRA. The mode of
inheritance appears from pedigree information to be autosomal
recessive. While the age of diagnosis is most commonly at a
PLoS ONE | www.plosone.org 1 June 2011 | Volume 6 | Issue 6 | e21452
relatively late age of approximately 6 years there is a great deal of
variation within the breed. In the closely related Labrador
Retriever breed, the only known form of PRA is called progressive
rod cone degeneration (prcd-PRA) [8], a form of PRA that affects
at least 22 breeds. To date only the prcd-PRA mutation has been
associated with PRA in the GR. However, only a small number of
PRA-affected golden retrievers have been found to be homozygous
for the prcd-mutation. Worldwide the GRs for which PRA can be
explained by the mutation in the prcd gene are in the minority [23].
Here we report the identification of a single base insertion
mutation in SLC4A3, a gene encoding a solute carrier protein that
is expressed in the retina. The mutation causes a shift in the
reading frame resulting in a subsequent premature termination
codon. We present evidence that this mutation represents a major
susceptibility locus for late onset PRA, known hereafter as
GR_PRA1, in Golden Retrievers.
Results
Prcd-PRA screening
All dogs displaying clinical signs typical of PRA, including a
hyper-reflective tapetum and attenuated blood vessels, were
diagnosed as affected with PRA (Figure S1).
To exclude the possibility that the affected GRs were positive for
the mutation already known to cause prcd-PRA, all 80 of our GR
cases were investigated for the previously described, autosomal
recessive prcd-PRA mutation [8]. None of the affected GRs tested in
this study was found to be homozygous for the prcd-PRA mutation.
A single individual was heterozygous (G/A) while the remaining 79
were homozygous for the wildtype (normal) allele (G/G).
Genome–wide Association Mapping
Genome-wide association analysis of genotyping data from 46
GR dogs, 27 cases and 19 controls over the age of 8 when last
examined, genotyped with 14,389 SNPs revealed a genome-wide
significant association on chromosome 37 (CFA37; Praw=1.14610
211,
Pgenome = 1.0610
25). Some of the dogs used were known to be
related through established pedigrees and therefore the presence of
population stratification was expected. Identity-by-state (IBS)
clustering in PLINK using genome-wide SNP marker data
confirmed the presence of population stratification with a genomic
inflation factor of 1.44. The signal on CFA37 remained significant
(Praw = 1.94610
210, Pgenome = 1.0610
25) after correction for this
by analysing for association within the IBS clusters and combining
the resulting evidence with Cochran-Mantel-Haenszel (CMH)
meta-analysis in PLINK [24] (Fig 1). The significantly associated
region on CFA37, defined as the region encompassing significantly
associated SNPs, extended from 28.331 to 29.847 Mb with the
most significantly associated SNP (BICF2G630131493) at
29.277 Mb. In addition, a number of weaker signals were seen
on other chromosomes including 19, 24 and 29, but only one
marker on CFA24 reached near-significance (Praw = 4.04610
25,
Pgenome = 0.052). Using homozygosity mapping we identified two
overlapping homozygous regions on CFA37 from 27.813 to
29.277 Mb and 28.633 to 29.878 Mb (Fig 2) and most of the PRA
cases (23/27) analysed were homozygous for one or both of these
regions. These homozygous regions overlap from 28.633 Mb to
29.277 Mb on CFA37 (Shared Block in Fig 2) and this 644 kb
region was defined as the PRA critical region. It is likely the four
dogs that do not carry the haplotype associated with the critical
region are affected with a form of PRA that is genetically distinct
from that addressed here.
Candidate gene sequencing
There are 27 genes within the PRA critical region (Table S3), of
which 25 have orthologous genes in the human and mouse.
NHEJ1 has been associated with Collie Eye Anomaly, an ocular
eye condition clinically distinct from PRA. None of the remaining
26 these genes have previously been associated with ocular
function or retinal degeneration in humans, however a solute
carrier anion exchanger gene (SLC4A3) located within this region
was identified as a strong candidate based on function and its
association with retinal degeneration in mice [25,26,27]. Align-
ment of canine, human and mouse genomic and coding sequences
revealed several inconsistencies and possible errors in the
prediction of exon-intron boundaries of canine SLC4A3 (Fig 3),
including missing exons that are probably due to gaps in the
reference sequence, perhaps due to extremely high GC content in
these regions. Primers were designed to ensure sequencing
coverage of all possible exons. To identify possible causal
mutations at this locus, we sequenced 20 of the 23 SLC4A3 exons
and splice sites in genomic DNA from six GRs (two PRA-affected
dogs, two obligate carriers and two unaffected dogs). DNA from a
Miniature Long-Haired Dachshund and a Border Collie, chosen
Figure 1. Genome-wide association mapping of PRA in Golden Retrievers. 2Log10 of p-values after correction for multiple testing and
population stratification with 100 000 permutations and IBS clustering, respectively. The dashed lines indicate the 5% significance level. A) 2Log10
plot of genome-wide association results show a strong statistical signal on CFA37 (Praw = 1.94610
210, Pgenome = 1.00610
25). CFA39 represents the X
chromosome. The most significant of the raw and permuted values are indicated. B) The statistically associated SNPs on CFA37 span 1.6 Mb from
28.331 Mb to 29.847 Mb.
doi:10.1371/journal.pone.0021452.g001
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randomly, was also sequenced as additional controls. The
CanFam2.0 reference sequence and annotation for SLC4A3 is
incomplete and includes two gaps that cover exons 1, 2 & 7 of the
gene (Fig 3C). All attempts at sequencing across the two gaps were
unsuccessful. Comparison of our sequence data with the canine
reference genome sequence revealed 50 sequence variants. Five of
the sequence variants showed perfect segregation with PRA within
the eight samples sequenced, and of these two are exonic (Fig 3C).
An A to C transversion at position 44 (c.A44C; CFA37:29,141,439)
resulting in a nonsynonymous substitution (p.Q15P) was found in
the first exon of the cardiac specific isoform, but does not affect the
full-length isoform also present in the eye (Fig 4). A comparison
among 33 eutherian mammals (data not shown) showed that the
position is not well conserved, indicating that the sequence variant
may not be functionally important. The second exonic change was a
frame shift mutation caused by the insertion of a single cytosine in
exon 16 (c.2601_2602insC; CFA37:29,147,633). It is predicted to
cause a premature stop codon in exon 18 (p.E868RfsX104) possibly
Figure 2. Fine mapping using haplotype analysis. SNP genotypes for 27 PRA cases and 19 PRA controls, over the 1.6 Mb region identified
during the GWA study. Fifteen of the cases share a homozygous haplotype of eight SNPS (Left Block) and 15 cases share another homozygous
haplotype of nine SNPS (Right Block). These two homozygous blocks overlap by just one SNP (Shared Block), defining the critical region of 644 kb
between 28.633 Mb and 29.277 Mb on CFA37, a region containing 27 genes. Four of the cases do not share any haplotypes with the other 23 cases,
but do share haplotypes with the controls.
doi:10.1371/journal.pone.0021452.g002
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resulting in degradation of the mRNA by nonsense-mediated decay
(NMD) or a truncated protein product (Fig 4). Exon 16 is included
in both the cardiac specific isoform and the full-length isoform of
SLC4A3 that are normally expressed in the retina [26]. While the
GR breed is known to suffer from hereditary cardiac diseases such
as Subvalvular Aortic Stenosis (SAS) and Cardiomyopathy there is
no evidence to indicate that dogs affected with GR_PRA1
experience any cardiac problems.
Transcript evaluation
All of the coding sequence of the SLC4A3 retinal transcripts,
from both the main isoforms (SLC4A3fl and SLC4A3c), was
successfully sequenced in a healthy dog revealing that both
isoforms are transcribed in the canine retina. In addition, our
results show intron-exon boundaries identical to those of the
human (Fig 3), which is in conflict with the boundaries predicted
by Ensembl genebuild for the canine gene.
Alternative splicing of exon 5 of the full-length isoform results in
two ‘‘full-length’’ isoforms that differ by the presence (SLC4A3fl1)
or absence (SLC4A3fl2) of 27 nucleotides at the 59 end. We were
unable to sequence the full 59 and 39 UTRs for any isoform. From
the sequencing of the retinal mRNA transcripts of all three
isoforms we discovered that canine SLC4A3fl1 (Genbank accession
no HQ379706) contains 1237 amino acids, SLC4A3fl2 (Genbank
accession no HQ379707) contains 1228 amino acids and SLC4A3c
(Genbank accession no HQ379708) contains 1030 amino acids,
Figure 3. Graphical comparison of the exons and exon-intron boundaries of human and canine SLC4A3. A) Human (Homo sapien)
SLC4A3. B) Canine (Canis familiaris) SLC4A3 as predicted by Ensembl genebuild. Sixteen of the genebuild exons predicted are identical to the human
exons (black). Exons 1, 4, 5 and 7 (grey) have differences in 59 and/or 39 exon-intron boundaries. Exon 6 (grey) shows no sequence similarity to its
human equivalent and is probably incorrect. C) Canine SLC4A3 exons confirmed by sequencing the retinal transcript. Exons 1, C1 and the correct exon
7 have not been predicted by Ensembl genebuild. The locations of the five fully-segregating sequence variants (in two PRA cases, two obligate
carriers and four normal samples) are indicated, but only two are exonic and nonsynonymous. One of these is in the first exon of the cardiac isoform
only (c: A44C) while the other is found in both the cardiac (c: 1981_1982insC) and full-length (fl: 2601_2602insC) isoforms of SLC4A3.
doi:10.1371/journal.pone.0021452.g003
Figure 4. Graphical representation of the SLC4A3 protein. A) Both isoforms are made up of a transmembrane domain flanked on both sides by
a cytoplasmic domain (represented by C*). The number of amino acids that make up each domain are indicated. Several amino acids at the N-
terminus are unique to either the full-length (280 residues) or cardiac (73 residues) isoform, but the remainder of the protein is identical in both
isoforms. B) The locations of the two nonsynonymous SNPs in the confirmed canine SLC4A3 transcript. C) The cardiac isoform alone is affected by the
A44C SNP mutation (p.Q15P). Both isoforms are affected by the 2601_2602insC mutation. 867 amino acids at the N-terminus of the full-length protein
and 660 of the cardiac isoform are normal. However the insertion causes a shift in the reading frame of 104 amino acids, leading to a premature
termination codon. This results in a truncated protein product, lacking 266 residues of the C-terminus of both isoforms, if expressed. Therefore a large
part of the transmembrane region and the entire c-terminal cytoplasmic region is absent in the mutant proteins.
doi:10.1371/journal.pone.0021452.g004
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with molecular weights of 136 kDa, 135DA and 114 kDa
respectively, predicted using the ExPASy Proteomics Server [28].
Mutation screening
We screened 48 GR dogs (21 cases and 27 controls present in
the original GWA data set; Figure S2) for the two coding variants,
A44C and 2601_2602insC, to investigate the association of
both these variants with PRA and compare them with
BICF2G630131493. The genotypes of the two variants i.e.
homozygous wild-type, heterozygous and homozygous for the
rare variant were concordant in all but six dogs (Figure S3),
indicating the two variants are in very close linkage disequilibrium
(r2 = 0.9118). Both variants, A44C and 2601_2602insC, showed
significant allelic association with PRA (p= 3.461026 and
7.561026 respectively) although they were both less strongly
associated than BICF2G630131493 (p = 6.961027). However,
under a recessive model we determined that 2601_2602insC was
the most strongly associated (p = 7.961027) when compared with
A44C or BICF2G630131493 (p = 0.016 and p= 0.001 respective-
ly). Neither variant shows complete association with PRA, but
2601_2602insC has a stronger likelihood of a deleterious effect on
the protein. In addition, neither the nucleotide nor the amino acid
affected by A44C is conserved in 33 eutherian mammals (data not
shown). We therefore discarded this variant from further analysis.
Analysis of the segregation of 2601_2602insC with PRA in a
family of Swedish ancestry (Fig 5) indicates that GR_PRA1 is
recessive and fully penetrant.
We screened 897 additional GR dogs making a total of 945 GRs
tested for the 2601_2602insC variant (Table 1) to confirm that the
mutation is not a commonly occurring polymorphism in this
breed. 56.3% of known PRA cases were homozygous for the
2601_2602insC mutation (SLC4A32/2) and 87.2% of obligate
carriers were heterozygous (SLC4A3+/2). 99.7% of dogs known to
be clinically free of PRA were either carriers of the mutant allele
(10.4%) or homozygous for the wildtype allele (89.3%; SLC4A3+/+).
These GRs are from a number of different countries including
known PRA cases from the UK, Sweden, France and the USA
(Table 2). The mutation described here accounts for the majority of
PRA cases from the UK and Sweden, 60.0% and 76.0%
respectively. However it accounts for only a minority of PRA cases
from France and Finland, 12.5% and 33.3% respectively, and none
of the cases from the USA. A subset of the complete sample cohort,
108 from the UK, 109 from Sweden, 89 from France and 148 from
the USA, were used to calculate allele frequencies of 0.04, 0.06, 0.02
and 0.00 respectively.
To determine whether or not 2601_2602insC is causal for PRA
in other breeds we screened 48 dogs from four non-GR breeds
Figure 5. Segregation of GR-PRA1 in a family. GR-PRA1 appears to be recessive and fully penetrant, with the exception of one dog not yet
diagnosed. Individual 29 is not clinically affected with PRA, but did show ophthalmascopic signs of the disease at the age of 6. Individuals 31 and 32
were only 4 years old when examined at the same time as a number of relatives including their mother, and were diagnosed with early-stage PRA.
Individuals that formed part of the genome-wide association study are indicated with ‘‘*’’.
doi:10.1371/journal.pone.0021452.g005
Table 1. GR_PRA1 genotypes and PRA clinical status for 945
GRs.
PRA Clinical Status
Genotypei PRA Case PRA Carrier Clear Unknown Total
SLC4A32/2 45 (56.3%) 1 (2.5%) 1 (0.3%) 1 (0.2%) 48
SLC4A3+/2 8 (10.0%) 34 (87.2%) 39 (10.5%) 28 (6.1%) 109
SLC4A3+/+ 27 (33.7%) 4 (10.3%) 329 (89.2%) 428 (93.7%) 788
Total 80 39 369 457 945
iThe wildtype allele is represented by ‘‘+’’ and the mutant allele by ‘‘2’’.
doi:10.1371/journal.pone.0021452.t001
Mutant SLC4A3 Causes PRA in Golden Retriever Dogs
PLoS ONE | www.plosone.org 5 June 2011 | Volume 6 | Issue 6 | e21452
made up of PRA cases of unknown aetiology and unaffected dogs:
10 Gordon Setter (seven cases), 10 Irish Setter (5 cases), 10 Tibetan
Spaniels (eight cases) and 18 English Springer Spaniel (nine cases).
All 48 dogs were homozygous wild-type (SLC4A3+/+).
Finally, to determine whether 2601_2602insC is present in
healthy dogs of other breeds we screened a further 223 dogs from
three closely related breeds most likely to share polymorphisms
with the GR (49 Chesapeake bay retrievers, 82 Labrador retrievers
and 92 Flatcoat retrievers). All 223 dogs were homozygous wild-
type (SLC4A3+/+).
Discussion
Several forms of PRA are present in the GR, including the prcd
variant, but this mutation does not account for the majority of
cases, particularly in Europe. Using a genome-wide association
(GWA) analysis approach, we have identified a novel candidate
variant in the SLC4A3 gene that is likely to represent a major
susceptibility locus for PRA in the GR. We found that while this
mutation does not explain all cases of PRA in our study, suggesting
that there are additional loci causing PRA in this breed, it does
appear to be fully penetrant and a common cause of PRA in the
breed. In our study we tested 80 GRs with PRA for the prcd
mutation and found that only one dog was a carrier. Our findings
therefore indicate that PRA is caused by at least three mutations in
this breed.
SLC4A3 was identified as a strong candidate causal locus within
the PRA-critical region as it mediates Cl2/HCO3
2 exchange
across cellular membranes [27] and is expressed in various tissues
including the Mu¨ller and horizontal cells of the retina [26].
Interestingly, the effect of SLC4A3-deficiency has been described in
a knockout mouse model showing that a selective inner retina
defect is followed by photoreceptor degeneration [25], similar to
the retinal degeneration seen in many forms of PRA and RP.
SLC4A3 occurs in two main isoforms, SLC4A3fl (full length) and
SLC4A3c (cardiac), which have identical transmembrane and C-
terminal regions while the N-terminal amino acids differ (Fig 4A)
[26]. SLC4A3fl is expressed predominantly in the brain, but it is
also found in the gut, kidney [29], heart [30] and Mu¨ller cells of
the retina [26]. The cardiac isoform is expressed predominantly in
the heart [30] and also in the horizontal neurons of the retina [26].
The two exonic and nonsynonymous variants (c.A44C and
c.2601_2602insC) are in tight linkage disequilibrium (r2 = 0.9118)
for the 48 dogs screened for both mutations. In six dogs (three
cases, one obligate carrier and two unaffecteds) however, variant
alleles are not inherited together. Under an allelic model
BICF2G630131493 is more strongly associated with PRA than
either of the variants due to the heterozygous state of more of the
cases than either of the variants. However, PRA in the GR
appears to be inherited in an autosomal recessive manner and
under a recessive model the 2601_2602insC variant is most
strongly associated with PRA and it appears to be fully penetrant.
Interestingly, this variant along with prcd still does not account for
all cases of PRA in the GR indicating the presence of at least one
additional mutation for PRA in the breed that remains to be
identified.
Sequencing of SLC4A3 from healthy retinal mRNA served three
purposes. Firstly it confirmed the presence of ‘‘cardiac’’ and ‘‘full-
length’’ mRNA transcripts (SLC4A3c and SLC4A3fl respectively) in
the normal canine retina. Secondly it revealed that the exon-intron
boundaries predicted by genebuild for the dog are incorrect for
five of the first eight exons. They are instead identical to the
human and mouse boundaries. Thirdly it revealed exons
orthologous to part or all of human exons 1, 2, 3 and 8, that
are absent from the Ensembl canine predictions (Fig 3A). Two
large gaps in the reference sequence are found upstream of canine
exons 2 and 8, and it is very likely that the missing exons lie within
these gaps (Fig 3C). As is the case in humans and mice, canine
SLC4A3fl is alternatively spliced to produce two ‘‘full length’’
isoforms (SLC4A3fl1 and SLC4A3fl2). The functional implication of
the difference between these isoforms is currently unknown.
In order to further test the validity of the insertion mutation, we
screened 945 Golden Retrievers for the mutation (Table 1). We
found that 56.3% of the PRA cases, 87.2% of the obligate PRA
carriers and 99.7% of clinically unaffected dogs (which could be
clear of the mutation or carry a single copy) have SLC4A3
genotypes that are concordant with their clinical status. There
are two groups of dogs with genotypes discordant with their
phenotypes. The first comprises three PRA-clear dogs that are
SLC4A32/2 (one obligate carrier, one PRA-clear and one not
diagnosed as affected, but on re-examination is showing early signs
of PRA). All three dogs were examined by a veterinary
ophthalmologist at 4–7 years of age and as average age of onset
is approximately seven years they would not necessarily have been
displaying clinical signs at the time of their examination. Thus 93.8%
of dogs (45/48) homozygous for the mutation i.e. SLC4A32/2,
have developed PRA, suggesting that the mutation is fully penetrant,
or nearly so. The inheritance observed in a pedigree of 32 dogs
(18 cases) is supportive of a recessive mode (Fig 5). The second group
comprises 35 PRA-affected dogs that are not SLC4A32/2 and four
obligate carriers do not carry SLC4A32601_2602insC. It is formally
possible that the mutation has a dominant mode of inheritance with
incomplete penetrance, or complex trait or compound heterozygote
effects. However, we are pursuing these discordant cases in a
separate investigation, and preliminary results indicate that a locus
other than SLC4A3 or prcdmay be associated with PRA in these dogs
(unpublished).
The absence of the mutant SLC4A3 allele from non-GR breeds
tested, including some dogs affected with PRA, and from GRs of
US ancestry indicates that the mutation is rare and probably
confined to GR lines with European ancestry. The mutant allele
frequency of approximately 4% indicates that 1 in 576 GRs in the
Table 2. PRA cases grouped by country of origin and GR_PRA1 genotype.i
Genotype UK Sweden France Finland Canada USA Total
SLC4A32/2 5 (55.6%) 38 (76.0%) 1 (12.5%) 1 (33.3%) 0 (0.0%) 0 (0.0%) 45 (56.3%)
SLC4A3+/2 1 (11.1%) 4 (8%) 0 (0.0%) 0 (0.0%) 3 (100.0%) 0 (0.0%) 8 (10.0%)
SLC4A3+/+ 3 (33.3%) 8 (16.0%) 7 (87.5%) 2 (66.7%) 0 (0.0%) 7 (100.0%) 27 (33.7%)
Total 9 50 8 3 3 7
iAll of the cases are free of prcd-PRA.
doi:10.1371/journal.pone.0021452.t002
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UK is affected with this form of PRA. However this is likely an
over-estimate as a sample cohort collected for research is unlikely
to be representative of the UK GR population. The allele
frequency of approximately 6% in Sweden and 2% in France
indicate 1 in 280 GRs of Swedish ancestry and 1 in 2000 of French
ancestry are affected with this form of PRA. While it is always
difficult to predict allele frequencies with accuracy these cohorts
are probably more representative as the samples were not
recruited for any particular study. Although 2601_2602insC has
not been found in any GRs from the USA, including PRA cases,
we cannot rule out the possibility that GR_PRA1 may be present
in the US GR population as it is such a numerically large breed
and the number of cases we tested is very small. In addition, three
of the PRA cases that carry GR_PRA1 are Canadian dogs,
indicating the disease allele is present in North America.
The Solute carrier family 4, anion exchanger, member 3
(SLC4A3, aka AE3) protein is part of a group of Na+-independent
anion exchangers and it exchanges Cl2 for HCO3
2 [31]. Little is
known about the structure of the protein, but it is thought to be
similar to family member SLC4A1. SLC4 proteins are made up of
three structural domains (Fig 4A). At the N-terminus there is a
hydrophilic, cytoplasmic domain of between 400 and 700 amino
acids, followed by a hydrophobic, polytopic transmembrane
domain of approximately 500 amino acids and lastly a cytoplasmic
domain of between 30 and 100 amino acids at the C-terminal
end [29].
The mutation, 2601_2602insC (p.E868RfsX104) in SLC4A3fl
and 1981_1982insC (p.E661RfsX104) in SLC4A3c, occurs in
the transmembrane region and as a result is likely to affect both
full length and cardiac isoforms of the protein (Fig 4B and 4C).
The shift in the reading frame results in the incorrect sequence of
104 amino acids and the loss of 266 residues at the C-terminal
end of the protein. These residues constitute a large portion
of the transmembrane region and the complete C-terminal
cytoplasmic region. We have been unable to obtain retinal tissue
from a dog affected with PRA and can therefore not confirm
whether the protein is expressed in a truncated form or not
expressed at all due to nonsense-mediated decay of the mRNA
transcript. In the event of truncated protein expression function-
ally important regions or residues are lost. Glycosylphosphatidy-
linositol-linked carbonic anhydrase IV [32] and transmembrane
carbonic anhydrase IX [33] interact with exofacial portions
of the transmembrane domains and the C-terminal tail of
the SLC4 polypeptides contains acidic motifs that may serve as
cytoplasmic carbonic anhydrase II (CAII) [34,35] binding sites,
all of which affect HCO3
2 homeostasis in the retina. Dahl et al
found that a deletion of the C-terminal tail resulting in a lack
of the CAII-binding site led to a loss of Cl2/HCO3
2 exchange
[36]. A number of possible functions for SLC4A3fl in Mu¨ller cells
have been proposed including: 1) Intracellular CO2 released
by photoreceptors is converted into HCO3
2 and H+ by carbonic
anhydrases. It is thought that removal of these products into
the blood or vitreous is facilitated by transporters such as SLC4A3
in the Mu¨ller cell end feet [37]. 2) SLC4A3fl may facilitate the
exchange of intracellular HCO3
2 for extracellular Cl2, thereby
contributing to pH maintenance [26] and a lack of bicarbonate
in the retina results in loss of retinal function [38]. 3) Finally it
may play a role in Cl2 level maintenance which potentially
affects Cl2-dependent transporter activity e.g. transporters of
c-Aminobutyric acid (GABA) and taurine [39]. Horizontal cells
also express various carbonic anhydrases which could in turn
create significant levels of intracellular HCO3
2. By exchanging
this HCO32 with extracellular Cl2, SLC4A3 may contribute to
pHi homeostasis [26].
PRA caused by the mutation described here has an average age
at diagnosis of 6.64 years and this is indicative of a late age of onset
(data not shown). The two affected individuals that were diagnosed
at the relatively young age of 4 years (Individuals 31 and 32 in
Fig 5) were examined at the same time as a number of relatives
including their mother. In these two dogs the disease was in the
early stages. The late age at diagnosis corresponds to the late-onset
findings of Alvarez et al where SLC4A3 knockout mice appeared
completely normal at 4 months of age [25]. However on closer
investigation the mice displayed an inner retina defect from birth,
which led to a failure of phototransduction at 4 months, followed
by pathological signs of photoreceptor degeneration at 8 months
and eventually complete blindness. Pathological signs included
defects in retinal blood vessels, the optic nerve head and rod
bipolar cells [25], consistent with most forms of PRA. SLC4A3
deficiency also resulted in increased expression of CAII and
CAXIV enzymes as well as the Na+/HCO3
2 co-transporter, NBC1,
in the horizontal and Mu¨ller cells. The authors hypothesised that
while these changes possibly compensated for the loss of SLC4A3 to
an extent, the ability of the cells to maintain acid-base balance is still
compromised, leading to late-onset photoreceptor cell death [25].
The discordant GR PRA cases i.e. SLC4A3+/+ and SLC4A3+/2
tended to develop PRA at an earlier age, with an average age at
diagnosis of 5.27 years (data not shown), which is consistent with the
segregation of a third form of PRA in the GR breed. It is becoming
increasingly apparent that even in breeds with small effective
population sizes, Mendelian conditions may be genetically hetero-
geneous. For example day blindness in the Alaskan Malamute breed
is caused by two or more mutations, only one of which is currently
known [40].
While PRA is widely considered to be the veterinary equivalent
of RP, the limited characterisation of many forms of PRA at a
cellular level suggests it may also be the equivalent of other retinal
degenerations such as cone and cone-rod dystrophy. Further
investigations are required to understand the cellular processes
involved in this form of PRA, including whether the rod or cone
photoreceptor cells are affected first. Alvarez et al identified
SLC4A3 as a candidate for hereditary vitreoretinal degenerations
(HVD) in humans based on their work on a knockout mouse [25].
Therefore PRA caused by the 2601_2602insC mutation should be
considered a potential model for all forms of human retinal
degeneration including Leber congenital amaurosis (LCA) or
cone-rod degeneration. Apart from the knockout mouse and the
mutation described here no other mutations in this gene have been
reported to be associated with retinal degenerations in any other
species.
The identification of a frameshift insertion in SLC4A3 in GR
dogs with PRA, that is likely to be a major susceptibility locus for
PRA in this breed, endorses the status of this gene as a candidate
for human retinal degenerations. In addition, this novel form of
PRA in the GR may prove to be a valuable model for further
studies to enhance our understanding of visual pathways and gene
therapy investigations.
Materials and Methods
Sample processing
All DNA samples were collected from privately owned pet dogs
with the owners’ consent. Sampling of blood from all Swedish dogs
was performed by the Department of Animal Breeding and
Genetics (SLU) according to ethical approval by the Swedish
Board of Agriculture (C138/6), and from US dogs by the Broad
Institute based on a protocol approved by the MIT CAC (*0907-
068-10 and 1109-127-12). All other DNA samples were collected
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as buccal swabs. Blood samples were collected into EDTA tubes
and genomic DNA was either extracted manually from peripheral
blood leukocytes using QIAamp DNA Blood Midi Kit (Qiagen,
Hilden, Germany) or automatically on a QIAsymphony SP/AS
instrument (Qiagen, Hilden, Germany). DNA was also extracted
from whole blood using a Nucleon Genomic DNA Extraction Kit
(Tepnel Life Sciences, Manchester, UK), according to the
manufacturer’s instructions. For samples collected as buccal
mouth swabs, DNA was extracted using a QIAampH DNA Blood
Midi Kit (Qiagen, West Sussex, UK). A retinal tissue sample from
a dog of unknown breed that was free of PRA was taken post
mortem, with the owner’s consent. RNA was extracted using an
RNeasy Protect Mini Kit (Qiagen, West Sussex, UK) according to
the manufacturer’s instructions.
The diagnosis of individual dogs was determined by veterinary
ophthalmologists through the BVA/KC/ISDS (British Veterinary
Association/Kennel Club/International Sheep Dog Society) Eye
Scheme in the UK or the Swedish Kennel Club Eye Scheme in
Sweden. Cases were defined as dogs diagnosed as affected with
PRA on the basis that they displayed ophthalmoscopic signs
consistent with PRA including tapetal hyperreflectivity and
vascular attenuation. Controls were dogs free of inherited eye
disease of any kind, and at least 8 years old at the time of
examination for the genome wide association analysis or any age
for subsequent investigations. Blood and buccal cheek samples that
were used for the allele frequency investigations were donated by
owners or collaborators, were all collected under the same
conditions and with the same approval as described above and
were unrelated at the parent level.
Prcd-PRA screening
We genotyped DNA from 80 PRA-affected GRs for the prcd
mutation using the TaqMan allelic discrimination technique
(Applied Biosystems Inc., Foster City, CA) according to the
manufacturer’s instructions. Primers (Forward: 59-GGCCTT-
TCTCCTGCAGACT-39; Reverse: 59-CAGCTTCTCACGG-
TTGGAC-39) and PrimeTime Dual-Labelled Probes (G-probe:
59-FAM-AGCCATGTGCACCACCCTCT-BHQ-39 and C-probe:
59-HEX-TGAGCCATGTACACCACCCTCT-BHQ-39; IDT,
Glasgow, UK) were designed with Primer3 [41]. PCR ampli-
fication and allelic discrimination plate read and analysis were
carried out on a Techne Quantica Real Time Thermal Cycler
with the Quansoft software (Bibby Scientific Limited, Stafford-
shire, UK).
Genome-wide association mapping
CanineSNP20 BeadChips (Illumina Inc., San Diego, California,
USA) were used to obtain genotype calls for 22,362 SNPs using
DNA from 27 Swedish PRA cases and 19 Swedish controls. A
genome-wide association (GWA) analysis was conducted using the
software package PLINK [24]. SNPs with a minor allele frequency
,5% and missing genotype calls .10% were removed from the
analysis, resulting in a final data set of 14,389 markers. Sample call
rate was .97% for all samples. Identity-by-state (IBS) clustering
with PLINK was used to examine and adjust for population
stratification. As a correction for multiple testing, we repeated the
GWA analysis using the Max(T) permutation procedure in PLINK
(100,000 permutations). Homozygosity mapping analysis was
performed to narrow and define a critical region.
Gene sequencing
To design primers for amplification and sequencing of the
canine SLC4A3 gene, a ClustalW [42] alignment was pro-
duced using the Ensembl predicted canine SLC4A3 transcript
(ENSCAFG00000015723) and available known mouse (EN-
SMUSG00000006576) and human (ENSG00000114923) En-
sembl transcripts. Primers for amplification and sequencing of
exons were designed with Primer3 [41] in the introns for
amplification of genomic DNA (Table S1) and in exons for the
amplification of cDNA (Table S2). Twenty of the 23 exons of
SLC4A3 were amplified by polymerase chain reaction using
HotStarTaq Plus DNA Polymerase (Qiagen, West Sussex, UK)
in genomic DNA from six GRs that were included in the GWA
study (two cases, two obligate carriers and two controls) and DNA
from one Miniature Long-Laired Dachshund and one Border
Collie. Obligate carriers were dogs that are known to have
produced PRA-affected offspring. SLC4A3 mRNA sequence was
amplified by reverse-transcriptase PCR using SuperScriptHII
Reverse Transcriptase (Invitrogen, Paisley, UK) according to the
manufacturer’s instructions. PCR products were purified using 96-
well filter plates (Multiscreen HTS-PCR, Millipore, Billerica, MA).
Amplification products were sequenced on an ABI 3100 DNA
Analyzer using BigDye Terminator v3.1 (Applied Biosystems, Inc.,
[ABI], Foster City, CA). Sequence traces were assembled,
analysed and compared using the Staden Package [43].
Mutation screening
To further investigate two exonic, disease-segregating sequence
variants in a larger dataset exon 16 of the full-length isoform and exon
1 of the cardiac isoform were sequenced in 48 GRs, made up of 21
cases, 9 obligate carriers and 18 GRs clear of PRA. These two exonic
variants were analysed for association with PRA and compared with
the most associated SNP marker, BICF2G630131493, under allelic
and recessive models, using the software package PLINK [24]. The
suggestive causative mutation for GR_PRA1 in exon 16 was screened
in 945 GRs by PCR amplification using fluorescent primers
(Forward: 59-6-FAM-AGAGCAACCTTGTAACCCGTA-39 and
Reverse: 59-GGAAGAAGGCAATGAGAAAGG-39; IDT, Glas-
gow, UK) and subsequent fragment length polymorphism detection
using an ABI 3100 DNA Analyzer and GeneMapperH Software
(Applied Biosystems, Inc., [ABI], Foster City, CA). The panel of 945
GRs (including the 48 DNA samples already sequenced), was made
up of 80 PRA cases, 39 obligate carriers and 826 clear dogs or dogs
with unknown phenotypes of any age. In addition, samples from 48
dogs representing four other breeds that are known to be affected
with different forms of PRA and from 223 dogs representing three
breeds that are closely related to the GR breed were also included in
the mutation screening.
Supporting Information
Figure S1 Fundus changes observed in typical PRA. A)
The fundus of a healthy Golden Retriever. B) The fundus of a
Golden Retriever displaying signs typical of PRA in most breeds.
The tapetum, which is the layer of cells behind the retina, appears
hyper-reflective, the blood vessels are attenuated and the optic disc
is pale. The photos were taken on the same day from littermates
that were 6 years old.
(TIF)
Figure S2 Use of samples in subsequent analyses for
which genome wide SNP data is available. 27 cases (blue)
and 147 potential controls (grey) were genotyped on the SNP20
bead chip. The number of cases and controls used in each analysis
is indicated.
(TIF)
Figure S3 Concordance and association with PRA
of variants (2601_2602insC and A44C) and SNP
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BICF2G630131493. 35 cases are concordant at all 3 positions, 7
are concordant for the 2 variants and 6 are discordant. All 3
polymorphisms are significantly associated with PRA with a
recessive mode of inheritance but 2601_2602insC far more so than
A44C or BICF2G630131493.
(TIF)
Table S1 Candidate gene primers.
(XLS)
Table S2 Candidate gene reverse transcriptase prim-
ers.
(XLS)
Table S3 Genes in the canine 644 kb PRA-critical
region.
(XLS)
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